CG Life, an integrated marketing and communications agency focused on life science and healthcare, has acquired McDAY, a strategic marketing communications agency located in Philadelphia. CG Life made this acquisition following a standing, informal strategic relationship between the firms in order to expand its strategic communications expertise in the pharmaceutical and fine chemicals markets. This is the second acquisition CG Life has completed in 2020.
“We felt the synergy with the CG Life team from the first time we met. As a combined team, McDAY and CG Life offer emerging and established companies in pharma and other sectors tremendous experience and a wide range of strategic services,” said McDAY President Susan Stipa, who will continue to serve in that role. “While we are now part of a larger, more powerful team, we continue to combine scientific understanding with smart creativity to generate success and revenue for our clients. This is especially relevant in 2020 as our team is helping companies and organizations to navigate the impact of the public health crisis on marketing and communications.”
Stipa, who purchased McDAY in 2015 when she was a client of the agency, is a former Roche process chemical engineer with more than 35 years of experience in the pharmaceutical industry. Previously, she was SVP and Commercial Director for Foster Wheeler’s pharmaceutical division in Philadelphia.
Murad Sabzali, a founding partner of CG Life, added, “The union of our agencies has been coming for a while, so we are thrilled to finally and formally welcome McDAY into the CG Life family. This combination strengthens our unique insights into the interconnected worlds of pharmaceutical discovery, development, clinical recruitment and commercialization. By coming together, we have instantly become of even more benefit to the growing number of our clients working to develop new vaccines, therapies, diagnostic tests and other innovations to combat the pandemic.”